These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8012978)

  • 1. Limonene chemoprevention of mammary carcinoma induction following direct in situ transfer of v-Ha-ras.
    Gould MN; Moore CJ; Zhang R; Wang B; Kennan WS; Haag JD
    Cancer Res; 1994 Jul; 54(13):3540-3. PubMed ID: 8012978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limonene-induced regression of mammary carcinomas.
    Haag JD; Lindstrom MJ; Gould MN
    Cancer Res; 1992 Jul; 52(14):4021-6. PubMed ID: 1617679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoma induction following direct in situ transfer of v-Ha-ras into rat mammary epithelial cells using replication-defective retrovirus vectors.
    Wang BC; Kennan WS; Yasukawa-Barnes J; Lindstrom MJ; Gould MN
    Cancer Res; 1991 May; 51(10):2642-8. PubMed ID: 2021942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammary carcinomas induced in human c-Ha-ras proto-oncogene transgenic rats are estrogen-independent, but responsive to d-limonene treatment.
    Asamoto M; Ota T; Toriyama-Baba H; Hokaiwado N; Naito A; Tsuda H
    Jpn J Cancer Res; 2002 Jan; 93(1):32-5. PubMed ID: 11802805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfone metabolite of sulindac inhibits mammary carcinogenesis.
    Thompson HJ; Jiang C; Lu J; Mehta RG; Piazza GA; Paranka NS; Pamukcu R; Ahnen DJ
    Cancer Res; 1997 Jan; 57(2):267-71. PubMed ID: 9000566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of oncogenes from rat mammary tumors by a highly efficient retrovirus expression cloning system.
    Tsukamoto T; Huang T; Guzman RC; Chen X; Pascual RV; Kitamura T; Nandi S
    Biochem Biophys Res Commun; 1999 Nov; 265(1):7-12. PubMed ID: 10548482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in the frequency of activated ras oncogenes in rat mammary carcinomas with increasing N-methyl-N-nitrosourea doses or increasing prolactin levels.
    Zhang R; Haag JD; Gould MN
    Cancer Res; 1990 Jul; 50(14):4286-90. PubMed ID: 2194653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas.
    Kito K; Kihana T; Sugita A; Murao S; Akehi S; Sato M; Tachibana M; Kimura S; Ueda N
    Mol Carcinog; 1996 Oct; 17(2):78-83. PubMed ID: 8890956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of rat primary mammary tumors following dietary d-limonene.
    Elegbede JA; Elson CE; Tanner MA; Qureshi A; Gould MN
    J Natl Cancer Inst; 1986 Feb; 76(2):323-5. PubMed ID: 3080636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in the response of neu and ras oncogene-induced rat mammary carcinomas to early and late ovariectomy.
    Wang B; Kennan WS; Yasukawa-Barnes J; Lindstrom MJ; Gould MN
    Cancer Res; 1992 Aug; 52(15):4102-5. PubMed ID: 1353410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective retrovirus insertion activates c-Ha-ras protooncogene in an MNU-induced rat mammary carcinoma.
    Bera TK; Tsukamoto T; Panda DK; Huang T; Guzman RC; Hwang SI; Nandi S
    Biochem Biophys Res Commun; 1998 Jul; 248(3):835-40. PubMed ID: 9704014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between metastatic ability and H-ras oncogene expression in rat mammary cancer cells transfected with the v-H-ras oncogene.
    Kyprianou N; Isaacs JT
    Cancer Res; 1990 Mar; 50(5):1449-54. PubMed ID: 2105838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming the activity of mammary carcinoma suppressor gene in Copenhagen rats by v-H-ras oncogene transfer into mammary epithelial cells in situ.
    Wang B; Kennan WS; Yasukawa-Barnes J; Lindstrom MJ; Gould MN
    Cancer Res; 1991 Oct; 51(19):5298-303. PubMed ID: 1913652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against malignant conversion in SENCAR mouse skin by all trans retinoic acid: inhibition of the ras p21-processing enzyme farnesyltransferase and Ha-ras p21 membrane localization.
    Agarwal R; Mohan RR; Ahmad N; Mukhtar H
    Mol Carcinog; 1996 Sep; 17(1):13-22. PubMed ID: 8876671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
    Swanson SM; Christov K
    Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effect of a farnesyl protein transferase inhibitor in mammary and lymphoid tumors overexpressing N-ras in transgenic mice.
    Mangues R; Corral T; Kohl NE; Symmans WF; Lu S; Malumbres M; Gibbs JB; Oliff A; Pellicer A
    Cancer Res; 1998 Mar; 58(6):1253-9. PubMed ID: 9515813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harvey ras results in a higher frequency of mammary carcinomas than Kirsten ras after direct retroviral transfer into the rat mammary gland.
    Thompson TA; Kim K; Gould MN
    Cancer Res; 1998 Nov; 58(22):5097-104. PubMed ID: 9823318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfection of activated Ha-ras protooncogenes causes mouse mammary hyperplasia.
    Miyamoto S; Guzman RC; Shiurba RA; Firestone GL; Nandi S
    Cancer Res; 1990 Sep; 50(18):6010-4. PubMed ID: 2203525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased susceptibility to NMU-induced mammary carcinogenesis in transgenic rats carrying multiple copies of a rat ras gene driven by the rat Harvey ras promoter.
    Thompson TA; Haag JD; Lindstrom MJ; Griep AE; Lohse JK; Gould MN
    Oncogene; 2002 Apr; 21(18):2797-804. PubMed ID: 11973638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered gene expression profile in chemically induced rat mammary adenocarcinomas and its modulation by an aromatase inhibitor.
    Wang Y; Hu L; Yao R; Wang M; Crist KA; Grubbs CJ; Johanning GL; Lubet RA; You M
    Oncogene; 2001 Nov; 20(53):7710-21. PubMed ID: 11753649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.